All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Ceiling Effect | NCIT_C21126 | [The upper limit of efficacy where diminishing returns result from increasing dosages.] |
| Chemical Properties | NCIT_C17771 | [General term for compositional, structural, and reactivity- affecting qualities of chemical compounds.] |
| Single Convention on Narcotic Drugs | NCIT_C21127 | [The principal international treaty regulating availability of opioids. It classifies the opioids, and requires the registration of all handlers and the estimation of medical needs for opioids. It establishes rules concerning production, manufacture and distribution, and requires statistical reports. The Single Convention governs how opioids are shipped between countries, using a system of import and export approval. The treaty also defines to some extent the requirements for safe distribution within a country.] |
| Guideline | NCIT_C17564 | [A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels.] |
| Treatment Plan | NCIT_C60735 | [A document outlining the essential treatment issues which will be addressed. This may include the problem to be addressed, the proposed treatment, the treatment goal, the time frame to meet goals, and an estimate of the costs.] |
| Document | NCIT_C19498 | [A physical object, or electronic counterpart, that is characterized by containing writing which is meant to be human-readable.] |
| Psychological Dependence | NCIT_C21131 | [A behavioral pattern characterized by a craving for the mood-altering effects of a drug and an overwhelming preoccupation with obtaining and using the drug.] |
| CD40LG Gene | NCIT_C21132 | [This gene plays a role in the stimulation of B cells in immune responses.] |
| Hyperimmunoglobulin M Syndrome | NCIT_C3990 | [An immunodeficiency state characterized by very low serum IgG and IgA but either a normal or, more frequently, a markedly elevated concentration of polyclonal IgM.] |
| B-Cell Activation | NCIT_C19255 | [A set of events occurring in B lymphocytes following stimulation with cognate antigen. Crosslinking the B cell antigen receptor (surface immunoglobulin) leads to increased expression of MHC class II molecules, exit from the resting state (G0) into the G1 phase of the cell cycle, and in the case of a strong antigenic stimulus, proliferation.] |
| Verbal Rating Scale for Pain | NCIT_C21133 | [A pain rating scale that includes specific pain criteria and self-reported ratings based upon patient verbalizations.] |
| Wisconsin Brief Pain Questionnaire | NCIT_C21134 | [A self-administered questionnaire which measures pain at its worst, its least, average, and right now. Additionally, it uses a check list of adjectives to characterize the pain and information is collected on the impact of treatment and the impact of pain on function. (Dout, 1983)] |
| Drug Tolerance | NCIT_C21130 | [A reduction in the sensitivity to a drug following its repeated administration, in which increased doses are required to produce the same magnitude of effect previously produced by a smaller dose. This increase in dose may be necessitated by changes in the metabolism of the drug, or a cellular, physiological or behavioral adaptation to the effects of the drug.] |
| Biological Effect of Chemicals | NCIT_C19996 | |
| Generalized Arteriosclerosis | NCIT_C35769 | [Arteriosclerosis that is not localized.] |
| Histiocytoma | NCIT_C35765 | [A mesenchymal tumor composed of fibroblastic and histiocytic cells.] |
| Benign Fibrohistiocytic Neoplasm | NCIT_C6490 | [A benign mesenchymal neoplasm composed of fibrohistiocytic cells, spindle fibroblastic cells, and histiocytes, in a storiform pattern.] |
| Generalized Atherosclerosis | NCIT_C35767 | [Atherosclerosis that is not localized.] |
| Atherosclerosis | NCIT_C35768 | [Build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.] |
| Ciliary Body Mixed Cell Melanoma | NCIT_C35783 |